K Health | $50,000,000 | (Jul 2, 2024)
Fabriclore | $1,600,000 | (Jul 2, 2024)
Pieces for Developers | $13,500,000 | (Jul 2, 2024)
Certified by Founder
Lodge
DiogenX
start up
France
- Marseille
- 11/05/2023
- Series A
- $30,056,125
DiogenX is a preclinical stage biotech company committed to a single mission: to discover and develop innovative biologics as new therapeutics options for millions of Diabetic patients around the world.
Our lead program, originating from Dr Patrick Collombat’s laboratory, is based on a new approach targeting beta-cell failure throughout the stimulation of beta-cell functional recovery in diabetes. This novel mode of action will provide a unique solution to rebalance glucose/insulin homeostasis and thus offer clear clinically meaningful benefits.
DiogenX is headquartered in Marseille, with labs in Nice (France).
- Industry Biotechnology
- Website https://diogenx.com/
- LinkedIn https://www.linkedin.com/company/diogenx/
Wify Technologies | $2,993,443 | (Jul 2, 2024)
N-Power Medicine, Inc. | Undisclosed Amount | (Jul 2, 2024)
Waypoint Bio | $14,500,000 | (Jul 2, 2024)
Feather | $6,429,480 | (Jul 2, 2024)
Blueroomcare Business | Undisclosed Amount | (Jul 2, 2024)
Comet(INDIA) | $5,000,000 | (Jul 2, 2024)
Innatera | $21,000,000 | (Jul 2, 2024)
Cautio | $778,300 | (Jul 2, 2024)
heymax.ai | Gives You a Free Trip, Every Year. | $2,600,000 | (Jul 2, 2024)